Andrew Hill Investment Advisors’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$997K Buy
1,893
+1,331
+237% +$747K 0.74% 35
2026
Q1
$316K Sell
562
-9
-2% -$5.77K 0.28% 47
2025
Q4
$387K Buy
571
+75
+15% +$51.1K 0.29% 38
2025
Q3
$317K Sell
496
-3
-0.6% -$1.82K 0.25% 42
2025
Q2
$268K Sell
499
-1
-0.2% -$478 0.22% 47
2025
Q1
$210K Sell
500
-12
-2% -$5.21K 0.2% 43
2024
Q4
$212K Sell
512
-2,155
-81% -$945K 0.16% 49
2024
Q3
$1.35M Sell
2,667
-229
-8% -$111K 1.01% 31
2024
Q2
$1.41M Sell
2,896
-771
-21% -$387K 1.17% 29
2024
Q1
$1.98M Buy
3,667
+59
+2% +$32.2K 1.75% 29
2023
Q4
$2M Buy
+3,608
New +$1.69M 2.09% 26
2022
Q2
Sell
-2,889
Closed -$1.58M 50
2022
Q1
$1.58M Buy
2,889
+710
+33% +$373K 1.75% 23
2021
Q4
$1.43M Buy
+2,179
New +$1.37M 1.34% 25

Other funds holding IDXX

Andrew Hill Investment Advisors's IDXX Position: Q2 2026 in Review

Andrew Hill Investment Advisors increased its Idexx Laboratories (IDXX) stake by 237% in Q2 2026, buying an estimated $747K and bringing the position to 1,893 shares worth $997K. The position accounts for 0.74% of the portfolio, ranked #35.

Andrew Hill Investment Advisors first reported a position in IDXX in Q4 2021 and has held it in 13 quarters since. The position peaked at $2M in Q4 2023. 396 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Andrew Hill Investment Advisors held 1,893 shares of Idexx Laboratories worth $997K as of Q2 2026.
  • Andrew Hill Investment Advisors bought 1,331 Idexx Laboratories shares in Q2 2026, an estimated $747K.
  • Idexx Laboratories made up 0.74% of Andrew Hill Investment Advisors's portfolio in Q2 2026, its #35 holding.
  • Andrew Hill Investment Advisors first reported a position in Idexx Laboratories in Q4 2021 and has held it in 13 quarters since.
  • Andrew Hill Investment Advisors's Idexx Laboratories position peaked at $2M in Q4 2023.
  • 396 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Andrew Hill Investment Advisors's 13F filing for Q2 2026, filed 15 Jul 2026.